Related Experiment Video
Updated: Mar 10, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
Radhika Mathur1,2, Burak H Alver3, Adrianna K San Roman1,4
1Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
Genes encoding subunits of SWI/SNF (BAF) chromatin-remodeling complexes are collectively mutated in ∼20% of all human cancers. Although ARID1A is the most frequent target of mutations, the mechanism by which its inactivation promotes tumorigenesis is unclear. Here we demonstrate that Arid1a functions as a tumor suppressor in the mouse colon, but not the small intestine, and that invasive ARID1A-deficient adenocarcinomas resemble human colorectal cancer (CRC). These tumors lack deregulation of APC/β-catenin signaling components, which are crucial gatekeepers in common forms of intestinal cancer. We find that ARID1A normally targets SWI/SNF complexes to enhancers, where they function in coordination with transcription factors to facilitate gene activation. ARID1B preserves SWI/SNF function in ARID1A-deficient cells, but defects in SWI/SNF targeting and control of enhancer activity cause extensive dysregulation of gene expression. These findings represent an advance in colon cancer modeling and implicate enhancer-mediated gene regulation as a principal tumor-suppressor function of ARID1A.
Insights
ARID1A acts as a tumor suppressor in the mouse colon, preventing colorectal cancer (CRC) by regulating gene expression at enhancers. Its loss leads to invasive ARID1A-deficient adenocarcinomas, highlighting a novel mechanism in CRC development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- SWI/SNF (BAF) chromatin-remodeling complexes are frequently mutated in human cancers (~20%).
- ARID1A is the most commonly mutated subunit, but its role in tumorigenesis is not fully understood.
- APC/β-catenin signaling is critical in common intestinal cancers.
Purpose of the Study:
- To investigate the tumor-suppressive function of Arid1a in the mouse colon.
- To understand the mechanism by which ARID1A inactivation promotes colorectal cancer (CRC).
- To explore the role of ARID1A in regulating gene expression via chromatin remodeling.
Main Methods:
- Utilized mouse models to study Arid1a function in the colon and small intestine.
- Generated and characterized ARID1A-deficient adenocarcinomas.
- Analyzed gene expression and chromatin accessibility in ARID1A-deficient tumors.
- Investigated the targeting of SWI/SNF complexes to enhancers.
Main Results:
- Arid1a functions as a tumor suppressor in the mouse colon, but not the small intestine.
- ARID1A-deficient adenocarcinomas in mice closely resemble human CRC and lack APC/β-catenin pathway alterations.
- ARID1A targets SWI/SNF complexes to enhancers, coordinating with transcription factors for gene activation.
- ARID1B compensates for ARID1A loss, but SWI/SNF targeting and enhancer control are impaired, leading to widespread gene dysregulation.
Conclusions:
- ARID1A inactivation promotes tumorigenesis in the colon through dysregulation of enhancer-mediated gene expression.
- ARID1A's tumor-suppressive function is primarily linked to its role in controlling gene regulation at enhancers.
- This study provides a new model for colon cancer and implicates enhancer regulation in ARID1A-driven tumor suppression.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

